Biosynex SA (EPA:ALBIO)
France flag France · Delayed Price · Currency is EUR
0.9200
+0.0160 (1.77%)
Jul 31, 2026, 11:05 AM CET

Biosynex Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-58.14-43.4-35.6121.19106.68
Depreciation & Amortization
52.9420.5313.4621.362.04
Other Adjustments
-7.49-0.16-2.01-0.350.54
Changes in Other Operating Activities
6.812.914.51-37.260.58
Operating Cash Flow
-5.89-10.12-9.654.95109.83
Operating Cash Flow Growth
----95.50%247.17%
Capital Expenditures
-2.69-4.84-39.54-37.77-19.02
Sale of Property, Plant & Equipment
0.771.250.080.050.04
Cash Acquisitions
-0.05-1.01-16.05-9.74-10.96
Other Investing Activities
5.01-0.710.690.97
Investing Cash Flow
3.04-4.6-54.81-46.77-28.96
Short-Term Debt Issued
0.01----
Net Short-Term Debt Issued (Repaid)
0.01----
Long-Term Debt Issued
-0.1622.4117.6624.25
Long-Term Debt Repaid
-0.99-4.25-14.83-5.57-7.42
Net Long-Term Debt Issued (Repaid)
-0.99-4.097.5812.0916.83
Issuance of Common Stock
7.99--019.43
Repurchase of Common Stock
---3.22-1.73-20.08
Net Common Stock Issued (Repurchased)
7.99--3.22-1.73-0.66
Common Dividends Paid
----20.44-1.94
Other Financing Activities
-0.1-0.81-0.730.16
Financing Cash Flow
6.91-4.095.17-10.8114.4
Foreign Exchange Rate Adjustments
-0.253.29---
Net Cash Flow
3.81-15.52-59.3-52.6495.27
Free Cash Flow
-8.57-14.96-49.2-32.8390.82
Free Cash Flow Growth
----303.29%
FCF Margin
-9.01%-14.79%-70.43%-23.68%38.27%
Free Cash Flow Per Share
-0.46-1.39-4.92-1.6216.55
Levered Free Cash Flow
-2.15-18.8420.88-10.7455.37
Unlevered Free Cash Flow
10.61-6.64-29.9-31.836.96